

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition
Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health
Details : Through the acquisition, Arcadia expands its portfolio of products by including Senokot®, Betadine®, Colace®, and SlowMag™ Mg. Senna glycoside, also known as sennoside or senna, is a medication used to treat constipation and empty the large intestin...
Product Name : Senokot
Product Type : Miscellaneous
Upfront Cash : Undisclosed
June 05, 2023
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Purdue Pharma’s Avrio Health Launches Two Senokot® Dietary Supplement Products
Details : Senokot (Sennoside) blueberry pomegranate flavor is a new flavor of senokot laxative* gummies for gentle overnight relief for occasional constipation.
Product Name : Senokot
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 25, 2021
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sennosides
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
Details : Sennoside is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Colorectal Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 25, 2015
Lead Product(s) : Sennosides
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
